BridgeBio · 1 day ago
Associate Director, Compliance
BridgeBio is a pioneering biotech company focused on developing life-changing medicines for patients with unmet needs. They are seeking a compliance professional with healthcare compliance experience to design, operate, and enhance a program that supports compliant growth while translating complex regulations into scalable processes.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Support the design, enhancements, and implementation of policies, procedures, and controls across risk assessments, monitoring/auditing, training, and compliance communications
Advise internal clients on the healthcare compliance program, privacy and the related processes, partner with the business to proactively identify and mitigate areas of potential risk while supporting business strategic goals
Develop and deliver role-based training for field teams, home office functions, affiliates, and vendors—covering healthcare compliance and privacy expectations
Partner with Legal and business stakeholders to implement required privacy processes, (e.g., data mapping, vendor due diligence, DPIAs where appropriate, lawful basis/consent considerations, and data subject request coordination)
Review HCP tiers and contracts through BridgeBio’s HCP Management System
Manage Compliance Committee agendas, draft committee slides and present key topics as requested by the Chief Compliance Officer
Support Legal in investigations, as needed
Qualification
Required
5+ years of relevant healthcare compliance at a law firm, company and/or relevant government agency
J.D. degree from a nationally recognized law school
Experience building and driving data analytics in healthcare compliance space
Knowledge of data privacy laws in the US and outside the US
Must possess strong written and oral communication skills, ability to influence change/be a change agent, and be able to coach, mentor and train others
Very strong problem-solving mindset. Serve as thought partner to Compliance leadership. Able to act as a business partner actively engaging stakeholders across the organization in both pre-commercial and commercial environments
Comfortable navigating ambiguity and evolving business models
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
H1B Sponsorship
BridgeBio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (5)
2023 (4)
2022 (4)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Debt Financing· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase